Commercialization of a preclinical Magnetic Particle Imaging system with sub-millimeter resolution, nano-molar sensitivity, and integrated CT

Information

  • Research Project
  • 8904902
  • ApplicationId
    8904902
  • Core Project Number
    R43EB020463
  • Full Project Number
    1R43EB020463-01
  • Serial Number
    020463
  • FOA Number
    PA-11-335
  • Sub Project Id
  • Project Start Date
    5/1/2015 - 9 years ago
  • Project End Date
    4/30/2017 - 7 years ago
  • Program Officer Name
    SASTRE, ANTONIO
  • Budget Start Date
    5/1/2015 - 9 years ago
  • Budget End Date
    4/30/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/24/2015 - 9 years ago
Organizations

Commercialization of a preclinical Magnetic Particle Imaging system with sub-millimeter resolution, nano-molar sensitivity, and integrated CT

? DESCRIPTION (provided by applicant): The two dominant preclinical molecular imaging techniques, optical imaging and nuclear imaging, have technical limitations that hamper their use in applications requiring high resolution, longitudinal tracer imaging with absolute quantitation. We are developing a new molecular imaging modality, Magnetic Particle Imaging (MPI), which does not have these limitations and is capable of: nanomolar sensitivity, absolute quantitation of a tracer, resolution independent of depth, and monitoring a stable tracer for weeks to months. These capabilities make MPI complementary to existing molecular imaging techniques and give scientists a versatile new tool when imaging cancer, tracking therapeutic and immune cells, and imaging the cardiovascular system. MPI is best compared with nuclear medicine, in that both modalities see only the injected tracer, both modalities can see right through background tissue, and both modalities are translatable. The MPI technique works by directly detecting the nonlinear magnetization of iron-oxide tracers using low-frequency magnetic fields. MPI's method of direct detection is exquisitely sensitive and we have already demonstrated nanomolar sensitivities in prototype systems. Indeed, the theoretical sensitivity limit of MPI may be as low as a single tagged cell in a voxel. MPI is unrelated to Magnetic Resonance Imaging (MRI), and MPI scans cannot be acquired using a MRI imager. This project aims to develop the first MPI system tailored for pre-clinical researchers working with mouse and rat models. The proposed system will be the world's highest sensitivity and highest resolution tomographic MPI scanner, as well as the first MPI system with integrated CT. First, we will build a high strength field free line magnetic field gradient mounted to a rotating gantry o enable tomographic MPI imaging. We will then integrate CT to enable acquisition of a tissue reference image. Last, we will test the imager on phantoms and post mortem animals.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R43
  • Administering IC
    EB
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    348285
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
  • Funding ICs
    NIBIB:348285\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MAGNETIC INSIGHT, INC.
  • Organization Department
  • Organization DUNS
    078791637
  • Organization City
    NEWARK
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    945604806
  • Organization District
    UNITED STATES